Cited by 63Coenzyme Q10 studies and effectsAntioxidant Activity and Oxidative StressParaoxonase enzyme and polymorphisms

Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview

Open access
Mantle, David, Hargreaves, Iain·2019·Antioxidants

Abstract

Longevity is determined by a number of factors, including genetic, environmental and lifestyle factors. A major factor affecting longevity is the development of degenerative disorders such as cardiovascular disease, diabetes, kidney disease and liver disease, particularly where these occur as co-morbidities. In this article, we review the potential role of supplementation with coenzyme Q10 (CoQ10) for the prevention or management of these disorders. Thus, randomised controlled clinical trials have shown supplementation with CoQ10 or CoQ10 plus selenium reduces mortality by approximately 50% in patients with cardiovascular disease, or in the normal elderly population, respectively. Similarly, CoQ10 supplementation improves glycaemic control and vascular dysfunction in type II diabetes, improves renal function in patients with chronic kidney disease, and reduces liver inflammation in patients with non-alcoholic fatty liver disease. The beneficial role of supplemental CoQ10 in the above disorders is considered to result from a combination of its roles in cellular energy generation, as an antioxidant and as an anti-inflammatory agent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antiox8020044

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [45]Mantle D. Milford D. Hargreaves I.P. Chronic kidney disease and CoQ10 supplementation: An overview J. Kidney Care 2018 in press
  2. [74]Judy W. Ubiquinone and ubiquinol Proceedings of the Eighth Conference of the International CoQ10 Association Bologna, Italy 8–11 October 2015

Cited by

Sorted by citations

Authors
Mantle, D., & Hargreaves, I.
Affiliations
  • Pharma Nord (United Kingdom) (GB)
  • Liverpool John Moores University (GB)
Corresponding author
Mantle, David
Venue
Antioxidants
Publisher
MDPI AG
Published
2019-02-16
Volume
8
Issue
2
Pages
44
ISSN
2076-3921 (ISSN-L)
OpenAlex
W2914031145
Cited by
63
References
72
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 6 · 2021: 13 · 2020: 11 · 2019: 6
FWCI
0.79
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Liverpool John Moores University (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords
coenzyme Q10, longevity, degenerative diseases, cardiovascular disease, type 2 diabetes, chronic kidney disease, non-alcoholic fatty liver disease, selenium supplementation, mortality, glycemic control, antioxidants, anti-inflammatory agents, cellular energy metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review